— Shares gained more than 4% after the pharmaceutical company beat earnings expectations and reaffirmed full-year guidance, helping investors overlook underwhelming revenue. Viatris posted $932.
9 million in adjusted net income for the first quarter, beating the consensus estimate of $835.8 million from analysts polled by FactSet. But revenue came in at $3.72 billion, falling short of the $3.8 billion forecast from Wall Street.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: CNBC - 🏆 12. / 72 Lire la suite »